CURR OPIN RHEUMATOL - CURRENT OPINION IN RHEUMATOLOGY
Publications
- 2023
Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus
Akbarzadeh, R., Riemekasten, G. & Humrich, J. Y., 01.03.2023, In: CURR OPIN RHEUMATOL. 35, 2, p. 98-106 9 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research